DIALAB

DIALAB

Vienna, Austria· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12.5M

Overview

DIALAB is a well-established, privately-held Austrian diagnostics company with a global footprint, specializing in the manufacturing and distribution of in-vitro diagnostic (IVD) reagents and laboratory instruments. The company has successfully navigated the evolving regulatory landscape, achieving IVDR certification, and serves a broad international market through direct and OEM partnerships. With a focus on supporting clinical laboratories, DIALAB's business model is built on a portfolio of diagnostic tests and compatible instruments, positioning it as an integrated solutions provider in the competitive IVD sector.

Diagnostics

Technology Platform

Manufacturer of integrated in-vitro diagnostic (IVD) reagents and clinical laboratory instruments, with IVDR-certified manufacturing and OEM partnership capabilities.

Funding History

2
Total raised:$12.5M
Series A$10M
Seed$2.5M

Opportunities

The EU's IVDR regulation creates a high barrier to entry, benefiting established, certified manufacturers like DIALAB.
Global demand for cost-effective diagnostic solutions, particularly in emerging markets within its 100+ country network, offers significant expansion potential.
The OEM partnership model provides a scalable channel to reach new customers without direct marketing investment.

Risk Factors

Intense competition from large, multinational IVD corporations with greater R&D and marketing resources poses a constant threat.
The complexity and cost of maintaining full IVDR compliance for its entire portfolio present an ongoing regulatory and financial burden.
Technological disruption from new diagnostic modalities (e.g., molecular, point-of-care) could challenge its core lab-focused business.

Competitive Landscape

DIALAB competes in the global in-vitro diagnostics market, which is dominated by giants like Roche, Abbott, Siemens Healthineers, and Danaher. As a mid-sized player, it competes on factors such as product quality, customer service, cost-effectiveness, and flexibility, often targeting specific geographic regions or laboratory segments. It also faces competition from other specialized reagent and instrument manufacturers.